VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.86 Million EUR | 93.19% |
| 2022 | -27.38 Million EUR | -597.53% |
| 2021 | -3.92 Million EUR | -370.95% |
| 2020 | 1.44 Million EUR | 7.33% |
| 2019 | 1.35 Million EUR | 63.04% |
| 2018 | 828 Thousand EUR | 357.14% |
| 2017 | -322 Thousand EUR | -178.92% |
| 2016 | 408 Thousand EUR | -79.38% |
| 2015 | 1.97 Million EUR | 79.91% |
| 2014 | 1.1 Million EUR | 31.26% |
| 2013 | 838 Thousand EUR | 244.73% |
| 2012 | -579 Thousand EUR | -148.61% |
| 2011 | 1.19 Million EUR | 241.26% |
| 2010 | 349 Thousand EUR | -41.44% |
| 2009 | 596 Thousand EUR | 134.81% |
| 2008 | -1.71 Million EUR | -44.47% |
| 2007 | -1.18 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.41 Million EUR | -80.0% |
| 2024 Q1 | -785 Thousand EUR | -121.29% |
| 2023 Q3 | -1.61 Million EUR | -35.65% |
| 2023 Q4 | 3.68 Million EUR | 328.08% |
| 2023 Q1 | -3.04 Million EUR | 84.27% |
| 2023 FY | -1.86 Million EUR | 93.19% |
| 2023 Q2 | -1.19 Million EUR | 60.79% |
| 2022 Q2 | -4.6 Million EUR | -64.02% |
| 2022 FY | -27.38 Million EUR | -597.53% |
| 2022 Q3 | -386 Thousand EUR | 91.63% |
| 2022 Q4 | -19.32 Million EUR | -4906.74% |
| 2022 Q1 | -2.81 Million EUR | 32.97% |
| 2021 Q2 | -12 Thousand EUR | 68.42% |
| 2021 Q4 | -4.19 Million EUR | -829.04% |
| 2021 Q3 | 575 Thousand EUR | 4891.67% |
| 2021 FY | -3.92 Million EUR | -370.95% |
| 2021 Q1 | -38 Thousand EUR | 88.82% |
| 2020 Q1 | 365 Thousand EUR | 166.42% |
| 2020 Q4 | -340 Thousand EUR | -145.64% |
| 2020 Q2 | 741 Thousand EUR | 103.01% |
| 2020 FY | 1.44 Million EUR | 7.33% |
| 2020 Q3 | 745 Thousand EUR | 0.54% |
| 2019 Q1 | 464 Thousand EUR | 306.22% |
| 2019 FY | 1.35 Million EUR | 63.04% |
| 2019 Q2 | 586 Thousand EUR | 26.29% |
| 2019 Q3 | 163 Thousand EUR | -72.18% |
| 2019 Q4 | 137 Thousand EUR | -15.95% |
| 2018 Q2 | 237 Thousand EUR | -23.3% |
| 2018 Q3 | 507 Thousand EUR | 113.92% |
| 2018 Q4 | -225 Thousand EUR | -144.38% |
| 2018 FY | 828 Thousand EUR | 357.14% |
| 2018 Q1 | 309 Thousand EUR | -41.48% |
| 2017 Q3 | 185 Thousand EUR | 114.02% |
| 2017 Q1 | 285 Thousand EUR | 61.02% |
| 2017 FY | -322 Thousand EUR | -178.92% |
| 2017 Q4 | 528 Thousand EUR | 185.41% |
| 2017 Q2 | -1.32 Million EUR | -563.16% |
| 2016 FY | 408 Thousand EUR | -79.38% |
| 2016 Q3 | 295 Thousand EUR | 459.76% |
| 2016 Q4 | 177 Thousand EUR | -40.0% |
| 2016 Q2 | -82 Thousand EUR | -555.56% |
| 2016 Q1 | 18 Thousand EUR | -98.61% |
| 2015 Q4 | 1.29 Million EUR | 345.7% |
| 2015 Q3 | 291 Thousand EUR | 118.8% |
| 2015 Q1 | 258 Thousand EUR | -57.14% |
| 2015 FY | 1.97 Million EUR | 79.91% |
| 2015 Q2 | 133 Thousand EUR | -48.45% |
| 2014 Q1 | 226 Thousand EUR | -56.29% |
| 2014 Q2 | -60 Thousand EUR | -126.55% |
| 2014 Q3 | 332 Thousand EUR | 653.33% |
| 2014 Q4 | 602 Thousand EUR | 81.33% |
| 2014 FY | 1.1 Million EUR | 31.26% |
| 2013 Q4 | 517 Thousand EUR | 140.47% |
| 2013 Q3 | 215 Thousand EUR | 102.83% |
| 2013 Q2 | 106 Thousand EUR | 1225.0% |
| 2013 Q1 | 8000.00 EUR | 106.25% |
| 2013 FY | 838 Thousand EUR | 244.73% |
| 2012 Q2 | -165 Thousand EUR | 21.43% |
| 2012 FY | -579 Thousand EUR | -148.61% |
| 2012 Q3 | -92 Thousand EUR | 44.24% |
| 2012 Q4 | -128 Thousand EUR | -39.13% |
| 2012 Q1 | -210 Thousand EUR | -130.93% |
| 2011 Q2 | -151 Thousand EUR | 49.33% |
| 2011 Q3 | 961 Thousand EUR | 736.42% |
| 2011 FY | 1.19 Million EUR | 241.26% |
| 2011 Q4 | 679 Thousand EUR | -29.34% |
| 2011 Q1 | -298 Thousand EUR | -332.81% |
| 2010 Q2 | -76 Thousand EUR | -128.68% |
| 2010 Q1 | 265 Thousand EUR | 38.02% |
| 2010 FY | 349 Thousand EUR | -41.44% |
| 2010 Q4 | 128 Thousand EUR | 300.0% |
| 2010 Q3 | 32 Thousand EUR | 142.11% |
| 2009 Q1 | -84 Thousand EUR | 0.0% |
| 2009 Q3 | 400 Thousand EUR | 488.24% |
| 2009 FY | 596 Thousand EUR | 134.81% |
| 2009 Q4 | 192 Thousand EUR | -52.0% |
| 2009 Q2 | 68 Thousand EUR | 180.95% |
| 2008 Q2 | -753 Thousand EUR | 0.0% |
| 2008 FY | -1.71 Million EUR | -44.47% |
| 2007 FY | -1.18 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 498.99 Million EUR | 100.374% |
| Fresenius SE & Co. KGaA | -594 Million EUR | 99.686% |
| LIMES Schlosskliniken AG | 3.39 Million EUR | 154.91% |
| M1 Kliniken AG | 10.27 Million EUR | 118.152% |
| Maternus-Kliniken Aktiengesellschaft | -14.25 Million EUR | 86.919% |
| MEDICLIN Aktiengesellschaft | -10.77 Million EUR | 82.693% |
| RHÖN-KLINIKUM Aktiengesellschaft | 38.71 Million EUR | 104.818% |